BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32296024)

  • 1. DNA methylation markers in the diagnosis and prognosis of common leukemias.
    Jiang H; Ou Z; He Y; Yu M; Wu S; Li G; Zhu J; Zhang R; Wang J; Zheng L; Zhang X; Hao W; He L; Gu X; Quan Q; Zhang E; Luo H; Wei W; Li Z; Zang G; Zhang C; Poon T; Zhang D; Ziyar I; Zhang RZ; Li O; Cheng L; Shimizu T; Cui X; Zhu JK; Sun X; Zhang K
    Signal Transduct Target Ther; 2020 Jan; 5(1):3. PubMed ID: 32296024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.
    Guillaumet-Adkins A; Richter J; Odero MD; Sandoval J; Agirre X; Catala A; Esteller M; Prósper F; Calasanz MJ; Buño I; Kwon M; Court F; Siebert R; Monk D
    J Hematol Oncol; 2014 Jan; 7():4. PubMed ID: 24405639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
    Li Y; Liu S; Wang H; Mai H; Yuan X; Li C; Chen X; Wen F
    PLoS One; 2017; 12(3):e0173472. PubMed ID: 28278270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.
    Gebhard C; Glatz D; Schwarzfischer L; Wimmer J; Stasik S; Nuetzel M; Heudobler D; Andreesen R; Ehninger G; Thiede C; Rehli M
    Leukemia; 2019 Jan; 33(1):26-36. PubMed ID: 29925905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
    Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
    Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
    Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
    Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia.
    Bai J; Li L; Li Y; Chen Q; Zhang L; Xie X
    Oncol Rep; 2019 Jun; 41(6):3488-3498. PubMed ID: 31002356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome.
    Fan R; Zhang LY; Wang H; Yang B; Han T; Zhao XL; Wang W; Wang XQ; Lin GW
    Tohoku J Exp Med; 2012 Jun; 227(2):119-28. PubMed ID: 22706399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission.
    Nordlund J; Milani L; Lundmark A; Lönnerholm G; Syvänen AC
    PLoS One; 2012; 7(4):e34513. PubMed ID: 22493696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
    Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
    PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDRG2 and TLR7 as novel DNA methylation prognostic signatures for acute myelocytic leukemia.
    Ge F; Zhang P; Niu J; Pei X; Lian C; Yu R; Ma R; Zhang Y; Zhu Z; Sun K
    J Cell Physiol; 2020 Apr; 235(4):3790-3797. PubMed ID: 31613009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
    Zhang ZH; Zhang W; Zhou JD; Zhang TJ; Ma JC; Xu ZJ; Lian XY; Wu DH; Wen XM; Deng ZQ; Lin J; Qian J
    Mol Carcinog; 2018 Jun; 57(6):735-744. PubMed ID: 29457658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
    Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
    Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
    Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
    Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
    Martinelli S; Kanduri M; Maffei R; Fiorcari S; Bulgarelli J; Marasca R; Rosenquist R
    Epigenetics; 2013 Jul; 8(7):720-9. PubMed ID: 23803577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.